SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-19-047699
Filing Date
2019-10-08
Accepted
2019-10-08 17:28:08
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A tv530278-s1a.htm S-1/A 502121
2 EXHIBIT 1.1 tv530278_ex1-1.htm EX-1.1 245943
3 EXHBIIT 4.11 tv530278_ex4-11.htm EX-4.11 203818
4 EXHIBIT 4.12 tv530278_ex4-12.htm EX-4.12 214563
5 EXHIBIT 5.1 tv530278_ex5-1.htm EX-5.1 13368
6 EXHIBIT 23.1 tv530278_ex23-1.htm EX-23.1 2749
7 GRAPHIC lg_titan-pharma.jpg GRAPHIC 96517
8 GRAPHIC image_001.jpg GRAPHIC 3476
  Complete submission text file 0001144204-19-047699.txt   1315219
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-233722 | Film No.: 191143363
SIC: 2836 Biological Products, (No Diagnostic Substances)